GLPwatch
Trials (2167)
Page 7 of 37.
- Liraglutide for Low-responders After Bariatric Surgery
- Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
- A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
- Liraglutide Effects on Memory in Healthy Subjects
- Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
- A Study of LY3305677 in Participants With Type 2 Diabetes
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
- Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
- Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
- New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
- Liraglutide in Newly Onset Type 1 Diabetes.
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
- A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease
- Retrospective Analysis for Patients With Metabolic Syndrome
- A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
- Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
- Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide
- Efficacy of Oral Semaglutide in Overweight or Obesity
- Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
- Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
- Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
- Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
- Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
- Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
- Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
- Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
- Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
- Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- Comparison of Body Weight Change Through Different Smeglutide Administration Methods
- High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)
- Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
- Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
- A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
- A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
- Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
- Mazdutide for Weight Management and Gout in Adults With Obesity
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
- A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy
- Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
- Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
- Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
- Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
- Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
- Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity